RGEN doing very well again today. Word is getting out that this is a solid company. Very rare in biotech world. Check out financials. Earnings on May 2nd with real income. Being overly cautious is NOT advised.
It is not too late to get on board. I advise all serious biotech investors to read up on this company. The financials are more solid than any small biotech I have ever seen. They have re-focused their product line on real products that are producing millions each year. I am excited about RGEN. I advise all to consider this stock and quickly forget about LAFFY. It is my very best advice from The Grey Corner.
in good conscience, I must inform you one more time about Repligen. This is not pumping because the company is founded on a real product with real income and no debt. All are free to partake of this wonderful opportunity. You are welcome. Thank you.